Molecular imaging of brain tumors: A bridge between clinical and molecular medicine?

被引:26
|
作者
Schaller, B. J.
Modo, M.
Buchfelder, M.
机构
[1] Univ Gottingen, Dept Neurol Surg, D-37075 Gottingen, Germany
[2] Kings Coll London, Neuroimaging Res Grp, Ctr Cellular Basis Behav, Inst Psychiat, London WC2R 2LS, England
关键词
molecular imaging; brain tumors; positron emission tomography;
D O I
10.1007/s11307-006-0069-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
As the research on cellular changes has shed invaluable light on the pathophysiology and biochemistry of brain tumors, clinical and experimental use of molecular imaging methods is expanding and allows quantitative assessment. The term molecular imaging is defined as the in vivo characterization and measurement of biologic processes at the cellular and molecular level. Molecular imaging sets forth to probe the molecular abnormalities that are the basis of disease rather than to visualize the end effects of these molecular alterations and, therefore, provides different additional biochemical or molecular information about primary brain tumors compared to histological methods "classical" neuroradiological diagnostic studies. Common clinical indications for molecular imaging contain primary brain tumor diagnosis and identification of the metabolically most active brain tumor reactions (differentiation of viable tumor tissue from necrosis), prediction of treatment response by measurement of tumor perfusion, or ischemia. The interesting key question remains not only whether the magnitude of biochemical alterations demonstrated by molecular imaging reveals prognostic value with respect to survival, but also whether it identifies early disease and differentiates benign from malignant lesions. Moreover, an early identification of treatment success or failure by molecular imaging could significantly influence patient management by providing more objective decision criteria for evaluation of specific therapeutic strategies. Specially, as molecular imaging represents a novel technology for visualizing metabolism and signal transduction to gene expression, reporter gene assays are used to trace the location and temporal level of expression of therapeutic and endogenous genes. Molecular imaging probes and drugs are being developed to image the function of targets without disturbing them and in mass amounts to modify the target's function as a drug. Molecular imaging helps to close the gap between in vitro and in vivo integrative biology of disease.
引用
收藏
页码:60 / 71
页数:12
相关论文
共 50 条
  • [1] Molecular Imaging of Brain Tumors: A Bridge Between Clinical and Molecular Medicine?
    B. J. Schaller
    M. Modo
    M. Buchfelder
    Molecular Imaging and Biology, 2007, 9 : 60 - 71
  • [2] Molecular Imaging in Pediatric Brain Tumors
    Chiaravalloti, Agostino
    Filippi, Luca
    Ricci, Maria
    Cimini, Andrea
    Schillaci, Orazio
    CANCERS, 2019, 11 (12)
  • [3] Molecular Imaging (PET) of Brain Tumors
    Basu, Sandip
    Alavi, Abass
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2009, 19 (04) : 625 - +
  • [4] Molecular imaging of stem cell therapy in brain tumors: a step towards personalized medicine
    Sandu, Nora
    Schaller, Bernhard
    ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (04) : 601 - 605
  • [5] Imaging and treatment of brain tumors through molecular targeting: Recent clinical advances
    Zaccagna, Fulvio
    Grist, James T.
    Quartuccio, Natale
    Riemer, Frank
    Fraioli, Francesco
    Carac, Corradina
    Halsey, Richard
    Aldalilah, Yazeed
    Cunningham, Charles H.
    Massoud, Tarik F.
    Aloj, Luigi
    Gallagher, Ferdia A.
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 142
  • [6] Prologue: Relevance of molecular imaging in clinical medicine
    Zahi A Fayad
    Valentin Fuster
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 : S1 - S1
  • [7] Prologue: Relevance of molecular imaging in clinical medicine
    Fayad, Zahi A.
    Fuster, Valentin
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2008, 5 (Suppl 2): : S1 - S1
  • [8] Molecular imaging in neuroendocrine tumors: Molecular uptake mechanisms and clinical results
    Koopmans, Klaas P.
    Neels, Oliver N.
    Kema, Ido P.
    Elsinga, Philip H.
    Links, Thera P.
    de Vries, Elisabeth G. E.
    Jager, Pieter L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 71 (03) : 199 - 213
  • [9] Nuclear medicine, molecular imaging, and molecular medicine
    Phelps, ME
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (02) : 13N - 14N
  • [10] Molecular imaging of brain tumors with radiolabeled choline PET
    Calabria, Ferdinando Franco
    Barbarisi, Manlio
    Gangemi, Vincenzo
    Grillea, Giovanni
    Cascini, Giuseppe Lucio
    NEUROSURGICAL REVIEW, 2018, 41 (01) : 67 - 76